Implantable polymeric device for sustained release of buprenorphine

Details for Australian Patent Application No. 2003240493 (hide)

Owner Titan Pharmaceuticals, Inc.

Inventors Bucalo, Louis R.; Patel, Rajesh A.

Agent FB Rice

Pub. Number AU-B-2003240493

PCT Number PCT/US03/17401

PCT Pub. Number WO2003/101358

Priority 60/384,733 31.05.02 US

Filing date 2 June 2003

Wipo publication date 19 December 2003

Acceptance publication date 12 June 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/384,733 31.05.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-B-2003240493

12 June 2008 Application Accepted

  Published as AU-B-2003240493

9 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240494-MASS SPECTROMETER WITH IMPROVED MASS ACCURACY

2003240492-SYSTEM AND METHOD FOR IMPLEMENTING COMBINED PACKETIZED TDM STREAMS AND TDM CROSS CONNECT FUNCTIONS